Wells Fargo
WVE icon

Wells Fargo’s Wave Life Sciences WVE Stock Holding History

Wells Fargo’s Portfolio WVE Stock Details WVE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q2 		– Sell
-21,300
Closed -$119K – 7523
2021
Q1 		$119K Buy
+21,300
New +$205K ﹤0.01% 5406

Other funds holding WVE

RCM
RA Capital Management Boston, Massachusetts $11.5B AUM 168.77% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
GP
GSK plc London $602M AUM
MC
Maverick Capital Dallas, Texas $11.3B AUM 76.6% 1-Year Est. Return
DCM
Driehaus Capital Management Chicago, Illinois $17.3B AUM 211.34% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return
6CM
683 Capital Management New York $2.04B AUM 94.26% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
RAM
Readystate Asset Management Chicago, Illinois $2.93B AUM 18.57% 1-Year Est. Return

Wells Fargo's WVE Position: Q2 2026 in Review

Wells Fargo increased its Wave Life Sciences (WVE) stake by 13% in Q2 2026, buying an estimated $120K and bringing the position to 154,211 shares worth $896K. The position accounts for ﹤0.01% of the portfolio, ranked #4190.

Wells Fargo first reported a position in WVE in Q4 2015 and has held it in 41 quarters since. The position peaked at $18.2M in Q3 2018. 239 funds tracked by Wall St. Rank hold WVE as of Q2 2026.

  • Wells Fargo held 154,211 shares of Wave Life Sciences worth $896K as of Q2 2026.
  • Wells Fargo bought 18,038 Wave Life Sciences shares in Q2 2026, an estimated $120K.
  • Wave Life Sciences made up ﹤0.01% of Wells Fargo's portfolio in Q2 2026, its #4190 holding.
  • Wells Fargo first reported a position in Wave Life Sciences in Q4 2015 and has held it in 41 quarters since.
  • Wells Fargo's Wave Life Sciences position peaked at $18.2M in Q3 2018.
  • 239 funds tracked by Wall St. Rank held Wave Life Sciences as of Q2 2026.

Based on Wells Fargo's 13F filing for Q2 2026, filed 14 Aug 2026.